| 2013 |
PEGylation of interferon alpha 2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases
Journal Of Controlled Release |
Kaminskas, LM Ascher, DB McLeod, VM Herold, MJ Le, CP Sloan, EK Porter, CJH |